Marinus Pharmaceuticals Company Profile (NASDAQ:MRNS)

About Marinus Pharmaceuticals

Marinus Pharmaceuticals logoMarinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral capsule and oral liquid, intended to provide more treatment options to adult and pediatric patient populations in both acute and chronic care settings. Ganaxolone acts on the GABAA receptor, a target in the brain known for both anti seizure and anti anxiety effects through positive allosteric modulation. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MRNS
  • CUSIP:
Key Metrics:
  • Previous Close: $1.60
  • 50 Day Moving Average: $1.64
  • 200 Day Moving Average: $3.80
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.36
  • P/E Growth: 0.00
  • Market Cap: $31.21M
  • Outstanding Shares: 19,509,000
  • Beta: 2.03
Additional Links:
Companies Related to Marinus Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Marinus Pharmaceuticals (NASDAQ:MRNS) (?)
Ratings Breakdown: 4 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $9.50 (493.75% upside)

Analysts' Ratings History for Marinus Pharmaceuticals (NASDAQ:MRNS)
Show:
DateFirmActionRatingPrice TargetDetails
8/10/2016Jefferies GroupBoost Price TargetBuy$2.50 -> $3.00View Rating Details
6/28/2016Stifel NicolausReiterated RatingHoldView Rating Details
6/14/2016Goldman Sachs Group Inc.DowngradeBuy -> NeutralView Rating Details
6/14/2016Oppenheimer Holdings Inc.DowngradeOutperform -> Market PerformView Rating Details
6/14/2016Royal Bank Of CanadaDowngradeOutperform -> Sector Perform$14.00 -> $2.00View Rating Details
5/19/2015Janney Montgomery ScottReiterated RatingBuy$20.00View Rating Details
(Data available from 8/27/2014 forward)

Earnings

Earnings History for Marinus Pharmaceuticals (NASDAQ:MRNS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2016        
8/9/2016Q2($0.38)($0.46)ViewN/AView Earnings Details
5/2/2016($0.41)($0.37)ViewN/AView Earnings Details
3/7/2016Q416($0.45)ViewN/AView Earnings Details
10/29/2015($0.51)($0.35)ViewN/AView Earnings Details
8/4/2015($0.51)($0.37)ViewN/AView Earnings Details
5/11/2015($0.47)($0.50)ViewN/AView Earnings Details
3/12/2015($0.39)$0.62ViewN/AView Earnings Details
11/13/2014Q3 14($0.50)($0.22)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Marinus Pharmaceuticals (NASDAQ:MRNS)
Current Year EPS Consensus Estimate: $-1.65 EPS
Next Year EPS Consensus Estimate: $-1.18 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.40)($0.37)($0.39)
Q2 20162($0.40)($0.39)($0.40)
Q3 20162($0.41)($0.39)($0.40)
Q4 20162($0.44)($0.39)($0.42)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Marinus Pharmaceuticals (NASDAQ:MRNS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Marinus Pharmaceuticals (NASDAQ:MRNS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/8/2016Vii Lp CanaanMajor ShareholderSell149,154$1.50$223,731.00View SEC Filing  
8/4/2016Vii Lp CanaanMajor ShareholderSell145,583$1.50$218,374.50View SEC Filing  
7/29/2016Vii Lp CanaanMajor ShareholderSell24,540$1.71$41,963.40View SEC Filing  
7/27/2016Vii Lp CanaanMajor ShareholderSell20,589$1.81$37,266.09View SEC Filing  
7/26/2016Vii Lp CanaanMajor ShareholderSell20,380$1.81$36,887.80View SEC Filing  
7/25/2016Vii Lp CanaanMajor ShareholderSell270,750$1.90$514,425.00View SEC Filing  
4/21/2015Gail M FarfelInsiderSell30,000$9.48$284,400.00View SEC Filing  
8/5/2014Domain Partners Vi, L.P.Major ShareholderBuy419,744$8.00$3,357,952.00View SEC Filing  
8/5/2014Stephen M BlochDirectorBuy625,000$8.00$5,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Marinus Pharmaceuticals (NASDAQ:MRNS)
DateHeadline
investornewswire.com logoMarinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:MRNS)
www.investornewswire.com - August 26 at 9:16 AM
News IconMarinus Pharmaceuticals Inc. (NASDAQ:MRNS) announced top-line ... - Inside Trade (NASDAQ:MRNS)
insidetrade.co - August 25 at 6:13 PM
News IconNews review of 2 biotech stocks: Advaxis (NASDAQ:ADXS), Marinus Pharmaceuticals (NASDAQ:MRNS) - The Voice Registrar (NASDAQ:MRNS)
voiceregistrar.com - August 24 at 9:23 AM
investornewswire.com logoWill Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Hit $3 Price Target? - Investor Newswire (NASDAQ:MRNS)
www.investornewswire.com - August 19 at 6:12 PM
finance.yahoo.com logoMARINUS PHARMACEUTICALS INC Financials (NASDAQ:MRNS)
finance.yahoo.com - August 18 at 6:25 PM
nasdaq.com logoEagle Gets Its Wings, Busy Year Ahead For CPRX, VYGR On Track (NASDAQ:MRNS)
www.nasdaq.com - August 10 at 9:21 AM
sg.finance.yahoo.com logoMarinus Pharmaceuticals posts 2Q loss (NASDAQ:MRNS)
sg.finance.yahoo.com - August 10 at 9:21 AM
biz.yahoo.com logoMARINUS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:MRNS)
biz.yahoo.com - August 9 at 6:32 PM
biz.yahoo.com logoMARINUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a (NASDAQ:MRNS)
biz.yahoo.com - August 9 at 6:32 PM
finance.yahoo.com logo4:41 pm Marinus Pharmaceuticals reports 2Q16 net loss per share of ($0.46) vs. ($0.39) Capital IQ Consensus; No revenue (NASDAQ:MRNS)
finance.yahoo.com - August 9 at 6:32 PM
publicnow.com logoMarinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2016 Financial Results (NASDAQ:MRNS)
www.publicnow.com - August 9 at 6:32 PM
tradecalls.org logoMarinus Pharmaceuticals (MRNS) Shares are Down -3% - Trade Calls (NASDAQ:MRNS)
www.tradecalls.org - July 25 at 6:23 PM
News IconEquity Roundup: Stock Performance Focus on Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Press Telegraph (NASDAQ:MRNS)
presstelegraph.com - July 23 at 10:10 AM
News IconChecking in on Stock Volatility for: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Engelwood Daily (NASDAQ:MRNS)
www.engelwooddaily.com - July 21 at 6:35 PM
News IconMarinus Pharmaceuticals, Inc. (NASDAQ:MRNS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:MRNS)
www.engelwooddaily.com - July 21 at 9:08 AM
News IconInsiders Increasing Positions in: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Press Telegraph (NASDAQ:MRNS)
presstelegraph.com - July 21 at 9:08 AM
News IconShares Losing Ground in Session: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - TGP (NASDAQ:MRNS)
telanaganapress.com - July 19 at 6:24 PM
istreetwire.com logoStocks on the Move: Marinus Pharmaceuticals, Inc. (MRNS), Host Hotels & Resorts, Inc. (HST), The Coca-Cola ... - iStreetWire (NASDAQ:MRNS)
istreetwire.com - July 19 at 10:51 AM
streetupdates.com logoAnalysts Watching Stocks: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) , Vertex Pharmaceuticals Incorporated ... - Street Updates (NASDAQ:MRNS)
www.streetupdates.com - July 19 at 10:51 AM
News IconPerformance report of the company: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - News Oracle (NASDAQ:MRNS)
www.newsoracle.com - July 19 at 10:51 AM
News IconBiotech Stocks Worth a Closer Look: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), Eleven Biotherapeutics, Inc ... - The Voice Registrar (NASDAQ:MRNS)
voiceregistrar.com - July 19 at 10:51 AM
4-traders.com logoMarinus Pharmaceuticals : Market Volatility Continues to Drive Investor Interest in These 4 Companies (NASDAQ:MRNS)
www.4-traders.com - July 18 at 11:34 AM
news.cmlviz.com logoMarinus Pharmaceuticals Inc Stock Momentum at Critical Inflection Point - CML News (NASDAQ:MRNS)
news.cmlviz.com - July 17 at 5:44 PM
News IconIncreased Volatility Noted on Shares of: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Engelwood Daily (NASDAQ:MRNS)
www.engelwooddaily.com - July 17 at 5:44 PM
News IconAre Analysts Bullish Marinus Pharmaceuticals Inc (NASDAQ:MRNS) After Last Week? - Consumer Eagle (NASDAQ:MRNS)
www.consumereagle.com - July 17 at 5:44 PM
News IconStock under consideration: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - News Oracle (NASDAQ:MRNS)
www.newsoracle.com - July 17 at 5:44 PM
investornewswire.com logoStrong Sell Calls For Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) At 0 - Investor Newswire (NASDAQ:MRNS)
www.investornewswire.com - July 15 at 10:50 AM
News IconMarinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:MRNS)
www.engelwooddaily.com - July 14 at 6:32 PM
News IconTrending Stocks In The News: Marinus Pharmaceuticals Inc (NASDAQ:MRNS), Himax Technologies, Inc. (ADR ... - NYSE Journal (press release) (NASDAQ:MRNS)
stockznews.com - July 14 at 6:32 PM
streetupdates.com logoNoteworthy Price Swings: EXACT Sciences Corporation (NASDAQ:EXAS) , Marinus Pharmaceuticals, Inc. (NASDAQ ... - Street Updates (NASDAQ:MRNS)
www.streetupdates.com - July 14 at 6:32 PM
News IconStock Volatility Focus for: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Engelwood Daily (NASDAQ:MRNS)
www.engelwooddaily.com - July 12 at 6:33 PM
News IconSession Volatility Review for: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Engelwood Daily (NASDAQ:MRNS)
www.engelwooddaily.com - July 12 at 6:33 PM
News IconShares Charging Upward in Session: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Telanagana Press (NASDAQ:MRNS)
telanaganapress.com - July 12 at 6:33 PM
News IconWere Analysts Bearish Marinus Pharmaceuticals Inc (NASDAQ:MRNS) This Week? - Engelwood Daily (NASDAQ:MRNS)
www.engelwooddaily.com - July 9 at 5:47 PM
News IconIncreased Volatility on Shares of: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Engelwood Daily (NASDAQ:MRNS)
www.engelwooddaily.com - July 8 at 6:22 PM
news.cmlviz.com logoMarinus Pharmaceuticals, Inc. Stock Momentum Hits Extreme Weakness - CML News (NASDAQ:MRNS)
news.cmlviz.com - July 8 at 9:11 AM
News IconCan Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:MRNS)
www.engelwooddaily.com - July 8 at 9:11 AM
investornewswire.com logoIs $2.5 Within Reach For Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)? - Investor Newswire (NASDAQ:MRNS)
www.investornewswire.com - July 8 at 9:11 AM
fiscalstandard.com logoBroker Outlook For Marinus Pharmaceuticals, Inc. (MRNS) - Fiscal Standard (NASDAQ:MRNS)
www.fiscalstandard.com - July 8 at 9:11 AM
News IconHow Many Marinus Pharmaceuticals Inc (NASDAQ:MRNS)'s Analysts Are Bullish? - Press Telegraph (NASDAQ:MRNS)
presstelegraph.com - July 3 at 5:45 PM
fiscalstandard.com logoMarinus Pharmaceuticals, Inc. (MRNS) Current Analyst Ratings - Fiscal Standard (NASDAQ:MRNS)
www.fiscalstandard.com - July 3 at 5:45 PM
streetinsider.com logoMarinus Pharma (MRNS) Says Primary Endpoint Not Met in Ganaxolone Phase 2 Exploratory Study (NASDAQ:MRNS)
www.streetinsider.com - June 30 at 9:10 AM
News IconWatching Stock Volatility for: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Engelwood Daily (NASDAQ:MRNS)
www.engelwooddaily.com - June 29 at 6:10 PM
News IconFrontline Matters in Notice- Marinus Pharmaceuticals (NASDAQ:MRNS), SolarCity (NASDAQ:SCTY), Iron Mountain ... - Seneca Globe (NASDAQ:MRNS)
www.senecaglobe.com - June 29 at 6:10 PM
ftsenews.co.uk logoMarinus Pharmaceuticals, Inc. (MRNS) Updated Price Targets - FTSE News (NASDAQ:MRNS)
www.ftsenews.co.uk - June 29 at 9:05 AM
News IconCovering the Bases on Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS): Where is the Stock Going? - Press Telegraph (NASDAQ:MRNS)
presstelegraph.com - June 28 at 6:09 PM
News IconCheck on Share Volatility: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Engelwood Daily (NASDAQ:MRNS)
www.engelwooddaily.com - June 28 at 6:09 PM
News IconExpectations Surging for Marinus Pharma (MRNS) Trial Data; Regulus Therapeutics (RGLS) Crashes On FDA's ... - Galaxy Stocks (press release) (registration) (NASDAQ:MRNS)
galaxystocks.com - June 28 at 6:09 PM
streetinsider.com logoMarinus Pharma (MRNS) Says Primary Endpoint Not Met in Ganaxolone Phase 2 Exploratory Study - StreetInsider.com (NASDAQ:MRNS)
www.streetinsider.com - June 28 at 6:09 PM
streetinsider.com logoMarinus (MRNS) Plans Conference Call to Reports Results From Phase 2 Study of Ganaxolone in Children with Fragile X (NASDAQ:MRNS)
www.streetinsider.com - June 28 at 11:08 AM

Social

Marinus Pharmaceuticals (NASDAQ:MRNS) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff